Cadila Healthcare spurts after strong Q1 results

Cadila Healthcare rose 4.09% to Rs 1,996.65at 15:03 IST on BSE after consolidated net profit rose 47.12% to Rs 353.39 crore on 22.37% increase in total income to Rs 2,521.48 crore in Q1 June 2015 over Q1 June 2014.

The result was announced during trading hours today, 12 August 2015.

Meanwhile, the BSE Sensex was down 289.72 points, or 1.04%, to 27,576.37.

On BSE, so far 16.32 lakh shares were traded in the counter, compared with an average volume of 11,838 shares in the past one quarter.

The stock hit a high of Rs 2,033.50 and a low of Rs 1,923 so far during the day. The stock hit a record high of Rs 2,045 on 17 July 2015. The stock hit a 52-week low of Rs 1,075.45 on 12 August 2014.

The stock had outperformed the market over the past one month till 11 August 2015, rising 1.55% compared with 0.74% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 15.65% as against Sensex's 1.30% rise.

The large-cap company has an equity capital of Rs 102.37 crore. Face value per share is Rs 5.

In a separate announcement during trading hours today, 12 August 2015, Cadila Healthcare said its board approved splitting each equity share with face value of Rs 5 into five equity shares of face of Re 1 each.

Cadila Healthcare is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News